Literature DB >> 17017698

Intra-operative acute leg ischaemia after free fibula flap harvest for mandible reconstruction.

P Astarci1, S Siciliano, R Verhelst, V Lacroix, P Noirhomme, J Rubay, A Poncelet, J C Funken, D Glineur, G El Kourhy.   

Abstract

Osteosarcomas of the cranial bones need a large surgical radical resection. The best option to reconstruct mandible defect after resection is the free fibula flap. In our patient an acute ischaemic leg occurred just after the free fibula flap harvest for mandible reconstruction. The abnormal distribution of the calf arteries leads to catastrophic consequences. The peroneal artery could be the main dominant artery of the leg in a small number of patients. We reported an extremely rare case of "peronea magna", described in less than 0.2% of the global population. A careful pre-operative workup of the calf vessels is required in all the patients who need free fibula flap harvest.

Entities:  

Mesh:

Year:  2006        PMID: 17017698     DOI: 10.1080/00015458.2006.11679921

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  3 in total

1.  Unilateral arteria peronea magna associated with bilateral replaced dorsalis pedis arteries.

Authors:  Wonsug Jung; Chang-Seok Oh; Hyung-Sun Won; In-Hyuk Chung
Journal:  Surg Radiol Anat       Date:  2008-04-08       Impact factor: 1.246

2.  Preoperative Angiography for Free Fibula Flap Harvest: A Case Series.

Authors:  Noor Alolabi; Haley Augustine; Forough Farrokhyar; Carolyn Levis
Journal:  Plast Surg (Oakv)       Date:  2021-05-05       Impact factor: 0.558

3.  Impact of Periosteal Branches and Septo-Cutaneous Perforators on Free Fibula Flap Outcome: A Retrospective Analysis of Computed Tomography Angiography Scans in Virtual Surgical Planning.

Authors:  Michael Knitschke; Anna Katrin Baumgart; Christina Bäcker; Christian Adelung; Fritz Roller; Daniel Schmermund; Sebastian Böttger; Philipp Streckbein; Hans-Peter Howaldt; Sameh Attia
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.